Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dixon, Bradley S
APPEAR-C3G, NCT04817618 / 2020-004589-21: Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. Jul 2024 - Dec 2024 : Submission for the adult C3G Jul 2024 - Dec 2024 : Submission in US for the adult C3G	Recruiting	3	98	Europe, Canada, Japan, US, RoW	Placebo, iptacopan, LNP023	Novartis Pharmaceuticals, Novartis Pharma AG	C3G	03/26	07/26
APPARENT, NCT05755386: Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN	Recruiting	3	106	Europe, Canada, Japan, US, RoW	Placebo, iptacopan	Novartis Pharmaceuticals	IC-MPGN	10/28	05/29